Clinical trial
Exercise as an Anti-inflammatory Treatment in Axial Spondyloarthritis Patients (axSpA): a Proof of Concept Study (ExTASI).
NCT04368494 is registered in ClinicalTrials.gov with Loughborough University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Exercise as an Anti-inflammatory Treatment in Axial Spondyloarthritis Patients (axSpA): a Proof of Concept Study (ExTASI).
- Lead sponsor
- Loughborough University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 1, 2021
- Completion date
- December 10, 2022
- Enrollment
- 20 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
arthritis, axial spondyloarthritis, inflammatory disease